Early Biomarkers as Predictors of Nephrology Trial Trajectory
Chronic kidney disease (CKD) and other nephrology conditions are a major global health challenge. With rising prevalence and persistent unmet…
Chronic kidney disease (CKD) and other nephrology conditions are a major global health challenge. With rising prevalence and persistent unmet…
The ADC market The first antibody drug conjugate (ADC) was approved in 2000 by pairing a cytotoxic chemotherapy agent with…
With cancer responsible for one in six deaths around the world, precision medicines based on the root cause of the…
Large molecule medicines are transforming treatment paradigms for many chronic and debilitating diseases, targeting previously “undruggable” pathways and marking a…
In pharmaceutical manufacturing, robust environmental monitoring is crucial for maintaining product quality and regulatory compliance. Historically, these practices have been…
Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same…
Each year in the US, more than 21,000 women will receive a new diagnosis of ovarian cancer according to the…
Nephrology has long been a difficult space for drug development: trials were slow, complex, high cost, and often unrewarding, constrained…
Sterile fill-finish is the critical final step of injectable drug production, ensuring patient safety by preventing microbial, bacterial, and particulate…
For years, healthcare organizations have focused on enabling clinical mobility by giving clinicians access to systems, communication tools, and patient…